MedPath

Telerehabilitation Program and Detraining in Patients With Post-COVID-19 Sequelae

Not Applicable
Completed
Conditions
COVID-19 Acute Respiratory Distress Syndrome
Interventions
Other: Telerehabilitation program
Registration Number
NCT05866224
Lead Sponsor
Campus docent Sant Joan de Déu-Universitat de Barcelona
Brief Summary

The primary objective of this study is to evaluate the effects of a 15-week home telerehabilitation program and a detraining period on cardiorespiratory fitness and muscular efficiency in patients with post-COVID-19 sequelae compared to a control group of COVID-19 patients. We hypothesize that cardiorespiratory fitness and muscular efficiency significantly improve in patients who carry out the home telerehabilitation program. However, the cardiorespiratory and muscular adaptations achieved and tolerance to exercise are lost over time as an effect of detraining.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
130
Inclusion Criteria
  • age > 18 years
  • molecular diagnosis (reverse transcription polymerase chain reaction [RT-PCR]) of infection by SARS-CoV-2
  • post-COVID-19 symptomatology
Exclusion Criteria
  • severe neurological disease
  • active oncological disease
  • neuromuscular disease and/or orthopedic disorders impeding normal development of cardiopulmonary exercise test
  • the absence of signed informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Supervised home telerehabilitation programTelerehabilitation programCOVID-19 patients will perform a total of 15 weeks of a telerehabilitation program combined with aerobic and strength exercises using the circuit training methodology. COVID-19 patients will carry out 3 weekly sessions on non-consecutive days to avoid unnecessary overload and maximize the adaptations, completing a total of 45 sessions
Primary Outcome Measures
NameTimeMethod
Ventilatory efficiency1 week per group

VE/VCO2 slope

Mechanical efficiency1 week per group

Delta efficiency in percentage

Cardiorespiratory fitness: relative oxygen uptake1 week per group

relative peak oxygen uptake in L/min

Exercise capacity during cardiopulmonary exercise test1 week per group

Exercise time in minutes and seconds

Cardiorespiratory fitness: absolute oxygen uptake1 week per group

absolute peak oxygen uptake in L/min

Power output during pedaling1 week per group

Power output in watts

Secondary Outcome Measures
NameTimeMethod
Respiratory exchange ratio1 week per group

RER

ventilatory equivalent for carbon dioxide1 week per group

VE/VCO2

Minute ventilation1 week per group

Ventilation in L/min

End-tidal partial pressure of oxygen1 week per group

PetO2 in mmHg

ventilatory equivalent for oxygen1 week per group

VE/VO2

end-tidal partial pressure of carbon dioxide1 week per group

PetCO2 in mmHg

Weight of COVID-19 patients1 week per group

Weight in kg

Height of COVID-19 patients1 week per group

Height in meters

Body mass index of COVID-19 patients1 week per group

BMI in kg/m2

Trial Locations

Locations (1)

Manuel Vicente Garnacho Castaño

🇪🇸

Sant Boi De Llobregat, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath